1. 1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC). (September 2015) Authors: Miles, D.; Cameron, D.; Bondarenko, I.; Lyudmila, M.; Alcedo, J.C.; Lopez, R.I.; Im, S.A.; Canon, J.L.; Shparyk, Y.; Yardley, D.; Masuda, N.; Ro, J.; Hubeaux, S.; Quah, C.; Bais, C.; O'Shaughnessy, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2274 Is there any role of adjuvant chemotherapy for T3N0M0 or T1N2M0 gastric cancer, stage II in 7th TNM but stage I in 6th TNM system?. (September 2015) Authors: Lee, H.J.; Lee, K.G.; Suh, Y.S.; Kong, S.H.; Oh, D.Y.; Im, S.A.; Bang, Y.J.; Yang, H.K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II—III breast cancer patients. (April 2018) Authors: Mo, H.; Kim, Y.; Rhu, J.; Lee, K.H.; Kim, T.Y.; Im, S.A.; Lee, E.S.; Lee, H.B.; Moon, H.G.; Noh, D.Y.; Han, W. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers. (December 2016) Authors: Yap, T.A.; Krebs, M.G.; Postel-Vinay, S.; Bang, Y.J.; El-Khoueiry, A.; Abida, W.; Harrington, K.; Sundar, R.; Carter, L.; Castanon-Alvarez, E.; Im, S.A.; Berges, A.; Khan, M.; Stephens, C.; Ross, G.; Soria, J.C. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD. (April 2018) Authors: Senkus-Konefka, E.; Domchek, S.M.; Im, S.A.; Xu, B.; Armstrong, A.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Conte, P.; Wu, W.; Goessl, C.; Runswick, S.; Robson, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗